Drug Profile
Echicetin
Latest Information Update: 01 Sep 1998
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antiplatelets
- Mechanism of Action GPIb receptor antagonists; Platelet aggregation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Thrombosis